Spots Global Cancer Trial Database for ly2510924
Every month we try and update this database with for ly2510924 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT02652871 | Leukemia | LY2510924 Idarubicin Cytarabine | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma | NCT01439568 | Extensive Stage... | LY2510924 Carboplatin Etoposide | 18 Years - | Eli Lilly and Company | |
A Study of LY2510924 and Durvalumab in Participants With Solid Tumors | NCT02737072 | Solid Tumor | LY2510924 Durvalumab | 18 Years - | Eli Lilly and Company | |
A Study of LY2510924 and Durvalumab in Participants With Solid Tumors | NCT02737072 | Solid Tumor | LY2510924 Durvalumab | 18 Years - | Eli Lilly and Company | |
A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma | NCT01391130 | Metastatic Clea... | LY2510924 Sunitinib | 18 Years - | Eli Lilly and Company | |
LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT02652871 | Leukemia | LY2510924 Idarubicin Cytarabine | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma | NCT01391130 | Metastatic Clea... | LY2510924 Sunitinib | 18 Years - | Eli Lilly and Company |